BCP Partnering Portal / Myriad Genetics GmbH

Myriad Genetics GmbH
Myriad Genetics GmbH

Myriad Genetics GmbH

Company Type:
Manufacturer
Business Address:
Leutschenbachstrasse 95
Zurich
8050
Switzerland
Industry:
Clinical / Diagnostics
Life Sciences
Scientific Services
Product Type:
Reagents & Kits
Products, Services & Applications:
Diagnostics
Custom Services
Diagnostics: Molecular
Personalised Medicine
About Us:

Myriad was an early pioneer and is currently a global leader in the exciting field of molecular diagnostics.

We are working to expand our reach by introducing new transformative molecular diagnostic tests in a number of diseases, like diabetes, depression, and rheumatoid arthritis. We also are focused on extending our mission internationally, in an effort to broaden our geographic footprint.

More Info About Our Products:

BRACAnalysis® - A predictive medicine product for hereditary breast and ovarian cancer.


COLARIS® - A predictive medicine product for Lynch syndrome.


COLARIS AP® - A predictive medicine product for adenomatous polyposis colon cancer syndromes.


MELARIS® - A predictive medicine product for hereditary melanoma.


PANEXIA® - A predictive medicine product for hereditary pancreatic and related cancers.


OnDose™ - A personalized medicine product to measure a patient's exposure to 5-FU chemotherapy.


PREZEON™ - A personalized medicine product to assess the status of the PTEN gene.


TheraGuide® - A personalized medicine product to predict toxicity to 5-FU-based chemotherapy.


Prolaris™ - A prognostic medicine product for prostate cancer.

Looking for Distributors in Regions:
Europe
South America
Head Office:
Myriad Genetics Inc (United States of America)
Sister Companies:
Myriad Genetics UK (None)
Myriad Genetics Brazil (Brazil)
>